Hepatitis B Top News Articles |
|
 Perinatal
HBV Transmission and Management of Pregnant Women with Hepatitis
B -
12/12/2008 |
 Do
HBeAg Negative Chronic Hepatitis B Patients with Low HBV Viral Load Require Liver
Biopsy? -
12/08/2008 |
 Tenofovir
(Viread) versus Adefovir (Hepsera) for the Treatment of Chronic Hepatitis B
-
12/05/2008 |
| Baseline
CD4 Cell Count Predicts HBV DNA Decline in HIV Negative and HIV Positive Patients
Treated with Adefovir (Hepsera) -
12/05/2008 |
| Hepatitis
B Virus Genotype Influences HBV Viral Load and Liver Fibrosis Progression
-
12/02/2008 |
| Simvastatin
(Zocor) Is Active against Wild-type and Drug-Resistant Hepatitis B
Virus -
11/21/2008 |
| Rescue
Therapy with Entecavir (Baraclude) plus Tenofovir (Viread)
Is Safe and Effective for Cirrhotic Hepatitis B Patients with Prior Treatment
Failures -
11/21/2008 |
| Adding
Ribavirin Does Not Improve Response to Pegylated Interferon for Chronic
Hepatitis B -
11/14/2008 |
| Tenofovir
(Viread) Produces Continued HBV Suppression through 96 Weeks in HBeAg
Positive and Negative Patients: Studies 102 and 103 -
11/07/2008 |
| Long-term
Entecavir (Baraclude) Reverses Liver Fibrosis
in HBeAg Positive and HBeAg Negative Chronic Hepatitis B Patients -
11/04/2008 |
 Hepatitis
B Virus Reverse Transcriptase Drug Resistance Mutations Lead to Treatment
Failure -
10/31/2008 |
 Antiviral
Therapy May Promote Hepatitis B Virus Genotype
Changes - 10/24/2008 |
 Hepatitis
B Persistence after HBsAg Clearance Is Associated with Increased Risk of Hepatocellular
Carcinoma - 10/21/2008 |
 Does
Hepatitis B Vaccination Raise the Risk of
Multiple Sclerosis? -
10/10/08 |
 Exposure
to Hepatitis B Virus May Increase the Risk of Pancreas
Cancer -
10/07/08 |
 Long-term
Efficacy and Safety of Adefovir (Hepsera)
for the Treatment of Chronic Hepatitis B in HBeAg Positive Patients -
10/03/08 |
 Sustained
HBeAg and HBsAg Loss in Chronic Hepatitis B Patients Treated
with Pegylated Interferon - 9/25/08 |
 CDC
Issues New Guidelines for Hepatitis B Testing and Management -
9/23/08 |
High
Pre-treatment ALT Levels May Predict Earlier HBeAg Seroconversion in Chronic Hepatitis
B Patients Treated with Lamivudine (Epivir-HBV)
- 9/16/08 |
 FDA
Approves First Hepatitis B Viral Load Test
-
9/09/2008 |
FDA
Warns of Potential Problems with Certain Prescription Drugs -
9/09/2008 |
HBV
Reactivation Leads to a High Risk of Fulminant Liver
Failure and Death - 9/05/08 |
Prior
Non-responders Respond Well to a Double Dose of Combined Hepatitis
A and B Vaccine - 8/29/2008 |
Experimental
Nasal Hepatitis B Vaccine Produces Immune
Response with a Single Dose in Animal Study - 8/29/2008 |
Tenofovir
(Viread) Effective against Entecavir-resistant Hepatitis
B Virus - 8/26/2008 |
Anticoagulant
Drug Warfarin May Slow Liver Fibrosis Progression
- 8/26/2008
|
FDA
Approves Gilead's Tenofovir (Viread) for Treatment of Chronic Hepatitis
B - 8/15/08 |
Liver
Cell Dysplasia Predicts Development of Hepatocellular
Carcinoma in Patients with Chronic Hepatitis B
- 8/01/08 |
Virological
and Histological Features and Predictors of Fibrosis
in Hepatitis B Patients with Persistently Normal ALT -7/29/08 |
HBV
and Hepatocellular Carcinoma Recurrence after Resection Surgery and
Liver Transplantation -
7/25/08 |
Tailored
Interferon Therapy Based on Individual Response
Produces Superior Results in Chronic Hepatitis B Patients -
7/22/08 |
| Prevalence
of Fibrosis and Cirrhosis in Patients with
Chronic Hepatitis B -
7/15/08 |
 Pharmasset
Announces New Trial to Study Clevudine plus Tenofovir
(Viread) for Chronic Hepatitis B -
7/11/08 |
FDA
Revises Process for Responding to Drug Approval Applications
from Pharmaceutical Companies -
7/11/08 |
UK
Health Agency Recommends Approval of Entecavir (Baraclude)
for Treatment of Eligible Patients with Chronic Hepatitis B -
6/24/08 |
Resistance
to Adefovir (Hepsera) and Lamivudine (Epivir-HBV)
in Chronic Hepatitis B Patients -
6/24/08 |
Adolescents
May Require Hepatitis B Vaccine Boosters
- 6/20/08
|
Association
between ALT and HBV DNA Viral Load in Chronic Hepatitis B Patients Treated with
Pegylated Interferon -
6/16/08 |
Association
between Hepatitis B and C Virus Infection
and Extrahepatic Bile Duct Cancer -
6/16/08 |
Safety,
Efficacy, and Pharmacokinetics of Adefovir (Hepsera)
in Children and Adolescents with Chronic Hepatitis B
- 6/13/08
|
Combination
Therapy with Lamivudine (Epivir-HBV) plus
Adefovir (Hepsera) for Chronic
Hepatitis B Prevents Resistance to Both Drugs -
6/10/08 |
Higher
HBV DNA Levels Linked to Increased Risk of Liver Cirrhosis
in People with Chronic Hepatitis B - 6/10/08 |
Chronic
Hepatitis B Patients with Normal or Minimally Elevated ALT and Detectable
HBV DNA May Experience Active Liver Disease Progression
- 6/06/08
|
Pegylated
Interferon Alfa-2a (Pegasys) Continues to
Suppress HBV, but Adding Adefovir (Hepsera)
Provides No Extra Benefit in PEG for B Trial
- 6/03/08
|
 High
Maternal HBV Viral Load, but Not HBeAg Status, Predicts Mother-to-child Hepatitis
B Transmission - 5/30/08 |
FDA
Proposes New Rule to Provide Updated Information on Use of Prescription Drugs
and Biological Products during Pregnancy and Breast-feeding - 5/30/08 |
Response
to Pegylated Interferon in Adolescents with
Chronic Hepatitis B - 5/23/08 |
HCV
May Inhibit HBV Replication in HCV-HBV Coinfected
Patients
|
Tenofovir
(Viread) Demonstrates Good Efficacy and Tolerability
in Hepatitis B Patients with Compensated Liver Cirrhosis
- 5/13/08
|
Tenofovir
May Be More Effective and Less Expensive than Lamivudine (Epivir-HBV)
and Adefovir (Hepsera) as First-line Treatment
for HBeAg- Chronic Hepatitis B - 5/09/08 |
Lamivudine
(Epivir-HBV) plus Adefovir (Hepsera)
Is an Effective Regimen for Lamivudine-resistant HBV Patients Who Develop Resistance
to Entecavir (Baraclude) - 5/09/08 |
Pegylated
Interferon plus Ribavirin Is Effective for Patients with HCV-HBV
Coinfection -
5/09/08 |
Entecavir
(Baraclude) Produces Greater Decrease in HBV
DNA than Adefovir (Hepsera) in Treatment-naive
HBeAg+ Patients: 96 Week Data from EARLY Study
- 5/06/08
|
Three
Years of Continuous Entecavir (Baraclude)
in Chinese Patients with Prior Lamivudine (Epivir-HBV)
Failure: Studies ETV-056 and ETV-050 -
5/06/08 |
Entecavir
(Baraclude) Treatment in Japanese Nucleoside-naive
Chronic Hepatitis B Patients -
5/06/08 |
R.E.V.E.A.L.-HBV
Study Shows Persistently High Hepatitis B Viral Load Raises the Risk
of Liver Cancer -
4/29/08 |
FDA-approved
Treatments
